Evidence map›Paper›PMID 32222968›Full record

ArticleJournal of neurochemistry2020

BDNF deficiency and enriched environment treatment affect neurotransmitter gene expression differently across ages.

Brittany E Dong, Hao Chen, Kazuko Sakata

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Journal of neurochemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Brittany E DongDepartment of Pharmacology, University of Tennessee Health Science Center, Memphis, TN, USA.
Hao ChenDepartment of Pharmacology, University of Tennessee Health Science Center, Memphis, TN, USA.
Kazuko SakataDepartment of Pharmacology, University of Tennessee Health Science Center, Memphis, TN, USA.ORCID 0000-0001-6509-216X
University of Tennessee Health Science Center · US

Funding

Heat shock factor HSF1 regulation of promoter-specific BDNF transcriptionR21NS101703 · NINDS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SAKATA, KAZUKO · 2018 to 2019
$418k
Neural Mechanisms of Inflexible Learning Caused by BDNF DeficiencyR21MH105567 · NIMH · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SAKATA, KAZUKO · 2014 to 2015
$375k
Antidepressive Effects and Gene Mechanisms of Early-life Enriched EnvironmentR03MH102445 · NIMH · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SAKATA, KAZUKO · 2014 to 2015
$148k
NIMH NIH HHS R03 MH102445NIMH NIH HHS R21 MH105567NINDS NIH HHS R21 NS101703
6 · The paper itself

Abstract

Deficiency of activity-induced expression of brain-derived neurotrophic factor (BDNF) disturbs neurotransmitter gene expression. Enriched environment treatment (EET) ameliorates the defects. However, how BDNF deficiency and EET affect the neurotransmitter gene expression differently across ages remains unclear. We addressed this question by determining the neurotransmitter gene expression across three life stages in wild-type and activity-dependent BDNF-deficient (KIV) mice. Mice received 2-months of standard control treatment (SCT) or EET at early-life development (ED: 0-2 months), young adulthood (2-4 months), and old adulthood (12-14 months) (N = 16/group). Half of these mice received additional 1-month SCT to examine persisting EET effects. High-throughput quantitative reverse transcription polymerase chain reaction measured expression of 81 genes for dopamine, adrenaline, serotonin, gamma aminobutyric acid, glutamate, acetylcholine, and BDNF systems in the frontal cortex (FC) and hippocampus. Results revealed that BDNF deficiency mostly reduced neurotransmitter gene expression, greatest at ED in the FC. EET increased expression of a larger number of genes at ED than adulthood, particularly in the KIV FC. Many genes down-regulated in KIV mice were up-regulated by EET, which persisted when EET was provided at ED (e.g., 5-hydroxytryptamine (serotonin) transporter [5HTT], ADRA1D, GRIA3, GABRA5, GABBR2). In both the regions, BDNF deficiency decreased the density of gene co-expression network specifically at ED, while EET increased the density and hub genes (e.g., GAT1, GABRG3, GRIN1, CHRNA7). These results suggest that BDNF deficiency, which occurs under chronic stress, causes neurotransmitter dysregulations prominently at ED, particularly in the FC. EET at ED may be most effective to normalize the dysregulations, providing persisting effects later in life. OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. More information about the Open Science badges can be found at https://cos.io/our-services/open-science-badges/.

Indexed as

AnimalsAnimals, NewbornBrainBrain-Derived Neurotrophic FactorGene ExpressionHousing, AnimalMiceMice, Inbred C57BLNeurogenesisNeurotransmitter AgentsBdnf protein, mouseBrain-Derived Neurotrophic FactorNeurotransmitter Agentsage-dependencybrain-derived neurotrophic factor (BDNF)early lifeenriched environmentgene co-expression networkneurotransmitter genes

Identifiers

PMID32222968
PMCPMC7319906
OpenAlexW3013964451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.